Priority Setting for the Children's Health Insurance Program Reauthorization Act (CHIPRA) Pediatric Quality Measures Program, 75469-75471 [2010-30262]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 232 / Friday, December 3, 2010 / Notices
Sunshine Act Meeting
TIME AND DATE:
December 8, 2010–10
a.m.
800 North Capitol Street, NW.,
First Floor Hearing Room, Washington,
DC.
STATUS: Part of the meeting will be in
Open Session and the remainder of the
meeting will be in Closed Session.
MATTERS TO BE CONSIDERED:
PLACE:
Open Session
1. Staff Update on Cruise West.
2. Initiative to Modernize Commission
Rules of Practice and Procedure.
Closed Session
1. Fact Finding No. 27: Complaints or
Inquiries from Individual Shippers of
Household Goods or Private
Automobiles—Discussion of the Fact
Finding Officer’s Interim Report.
2. Fact Finding Investigation No. 26:
Vessel Capacity and Equipment
Availability in the United States
Export and Import Liner Trades—
Discussion of the Fact Finding
Officer’s Final Report.
3. Petition No. P1–01: Petition of Hainan
P O Shipping Co., Ltd., for an
Exemption from the First Sentence of
Section 9(c) of the Shipping Act.
4. Staff Briefing and Discussion
Regarding Passenger Vessel Financial
Responsibility.
CONTACT PERSON FOR MORE INFORMATION:
Karen V. Gregory, Secretary, (202) 523–
5725.
[FR Doc. 2010–30438 Filed 12–1–10; 11:15 am]
BILLING CODE 6730–01–P
FEDERAL RESERVE SYSTEM
mstockstill on DSKH9S0YB1PROD with NOTICES
Change in Bank Control Notices;
Acquisitions of Shares of a Bank or
Bank Holding Company
The notificants listed below have
applied under the Change in Bank
Control Act (12 U.S.C. 1817(j)) and
225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire shares of a bank
or bank holding company. The factors
that are considered in acting on the
notices are set forth in paragraph 7 of
the Act (12 U.S.C. 1817(j)(7)).
The notices are available for
immediate inspection at the Federal
Reserve Bank indicated. The notices
also will be available for inspection at
the offices of the Board of Governors.
Interested persons may express their
views in writing to the Reserve Bank
indicated for that notice or to the offices
VerDate Mar<15>2010
16:09 Dec 02, 2010
Jkt 223001
A. Federal Reserve Bank of San
Francisco
(Kenneth Binning, Vice President,
Applications and Enforcement) 101
Market Street, San Francisco, California
94105–1579:
1. BOTC Holdings LLC, Lightyear Fund II,
L.P.; Lightyear Co-Invest Partnership II, L.P.;
Lightyear Fund II GP, L.P.; Lightyear Fund II
GP Holdings, LLC; Marron & Associates, LLC;
Chestnut Venture Holdings, LLC; Donald B.
Marron; Lightyear Capital LLC and Lightyear
Capital II, LLC, all of New York, New York;
to acquire voting shares of Cascade Bancorp,
and thereby indirectly acquire voting shares
of The Bank of the Cascades, both of Bend,
Oregon.
Governors not later than December 30,
2010.
A. Federal Reserve Bank of Richmond
(A. Linwood Gill, III, Vice President)
701 East Byrd Street, Richmond,
Virginia 23261–4528:
1. Old Line Bancshares, Inc., Bowie,
Maryland; to acquire 100 percent of the
voting shares of Maryland Bankcorp,
Inc., and thereby indirectly acquire
voting shares of Maryland Bank & Trust
Company, National Association, both of
Lexington Park, Maryland.
Board of Governors of the Federal Reserve
System, November 30, 2010.
Robert deV. Frierson,
Deputy Secretary of the Board.
Board of Governors of the Federal Reserve
System, November 30, 2010.
Robert deV. Frierson,
Deputy Secretary of the Board.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2010–30361 Filed 12–2–10; 8:45 am]
Agency for Healthcare Research and
Quality
of the Board of Governors. Comments
must be received not later than
December 20, 2010.
FEDERAL MARITIME COMMISSION
75469
BILLING CODE 6210–01–P
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The application also will be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
PO 00000
Frm 00019
Fmt 4703
Sfmt 4703
[FR Doc. 2010–30362 Filed 12–2–10; 8:45 am]
BILLING CODE 6210–01–P
Priority Setting for the Children’s
Health Insurance Program
Reauthorization Act (CHIPRA)
Pediatric Quality Measures Program
Agency for Healthcare Research
and Quality, HHS.
ACTION: Request for public comments.
AGENCY:
Section 401(a) of the
Children’s Health Insurance Program
Reauthorization Act of 2009 (Pub. L.
111–3) amended title Xl of the Social
Security Act by inserting after section
1139 the new section 1139A, ‘‘Child
Health Quality Measures.’’: Subsection
1139A(b), ‘‘Advancing and Improving
Pediatric Quality Measures,’’ directs the
Secretary to establish a pediatric quality
measures program to: improve and
strengthen the initial core child health
care quality measures established by the
Secretary under section 1139A(a);
expand on existing pediatric quality
measures used by public and private
health care purchasers and advance the
development of new quality measures;
and increase the portfolio of evidencebased, consensus pediatric quality
measures available to public and private
purchasers of children’s healthcare
services, providers, and consumers.
Section 1139A(b)(3) requires the
Secretary to consult with a broad range
of stakeholders to set these priorities. To
meet the requirement for extensive
stakeholder consultation, we are seeking
general public comment on these draft
priorities, and asking the public to
identify additional priorities as needed.
DATES: Comments on this notice must be
received by January 14, 2010. The
SUMMARY:
E:\FR\FM\03DEN1.SGM
03DEN1
mstockstill on DSKH9S0YB1PROD with NOTICES
75470
Federal Register / Vol. 75, No. 232 / Friday, December 3, 2010 / Notices
public comment period will close on
January 14, 2010 at 5 p.m. EST. Any
comments received after the close of the
comment period will not be considered.
ADDRESSES: You may submit comments
by any of the following methods:
1. Electronic Mail—CHIPRAquality
measures@AHRQ.hhs.gov.
2. Mail—Agency for Healthcare
Research and Quality, Attention: Office
of Extramural Research, Education, and
Priority Populations-Public Comment,
CHIPRA PQMP Priorities, 540 Gaither
Rd., Rockville, MD 20850.
Comments cannot be sent by facsimile
transmission, because of staff and
resource limitations. Please note that all
submissions may be posted without
change to https://www.AHRQ.gov/chipra,
including any personal information
provided.
FOR FURTHER INFORMATION CONTACT:
Denise Dougherty, PhD, Senior
Advisor, Child Health and Quality
Improvement, Office of Extramural
Research, Education, and Priority
Populations, Agency for Healthcare
Research and Quality, 540 Gaither Rd.,
Rockville, MD. 301–427–1868.
Denise.dougherty@ahrq.hhs.gov.
For information regarding this Notice,
please contact: CHIPRAquality
measures@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION: On
February 4, 2009, the Congress enacted
the Children’s Health Insurance
Program Reauthorization Act (CHIPRA)
of 2009 (Pub. L. 111–3)., Section 401(a)
of the legislation amended title XI of the
Social Security Act (the Act) to establish
section 1139A (42 U.S.C. 1320b-9a).
Subsection 1139A(b)(E) requires the
Secretary to consult with a wide
spectrum of national stakeholders to
identify gaps in existing pediatric
quality measures and establish priorities
for development and advancement of
such measures. The Secretary delegated
CHIPRA implementation to the Centers
for Medicare & Medicaid Services
(CMS). A ‘‘Memorandum of
Understanding ‘‘was entered into with
the Agency for Healthcare Research and
Quality (AHRQ), by which AHRQ
would conduct several activities in Title
IV. These included the identification of
an initial, recommended core set of
children’s healthcare quality measures
for voluntary use by Medicaid and CHIP
programs and establishment of the
Pediatric Quality Measures Program
(PQMP), both in collaboration with
CMS.
Pediatric Quality Measures Program
(PQMP). The PQMP was required to be
established by January 1, 2011, and
authorized to award grants and
contracts. The PQMP will consist of 7–
VerDate Mar<15>2010
16:09 Dec 02, 2010
Jkt 223001
9 cooperative agreement awards to
successful applicants to HS11–001
(https://grants.nih.gov/grants/guide/rfafiles/RFA–HS–11–001.html), and a
contract award to a CHIPRA
Coordinating and Technical Assistance
Center (https://www.ahrg.gov/chipra/
#CTAC), both supervised by AHRQ and
CMS. As required by CHIPRA,
successful applicants will work on
priorities for measurement methods and
topics set by HHS and informed by the
input of multiple stakeholders.
Multi-stakeholder consultation.
Section 1139A(b)(3) requires a
consultation process for establishing
priorities for the pediatric quality
measures program that requires
consultation with multiple stakeholders,
as follows:
‘‘ * * * the Secretary shall consult with:
‘‘(A) States;
(B) pediatricians, children’s hospitals, and
other primary and specialized pediatric
health care professionals (including members
of the allied health professions) who
specialize in the care and treatment of
children, particularly children with special
physical, mental and developmental health
care needs;
(C) dental professionals, including
pediatric dental professionals;
(D) health care providers that furnish
primary health care to children and families
who live in urban and rural medically
underserved communities or who are
members of distinct population sub-groups at
heightened risk for poor health outcomes;
(E) national organizations representing
children, including children with disabilities
and children with chronic conditions;
(F) national organizations representing
consumers and purchasers of children’s
health care;
(G) national organizations and individuals
with expertise in pediatric health quality
measurement; and
(H) voluntary consensus standards setting
organizations and other organizations
involved in the advancement of evidencebased measures of health care.’’
Measure topics: Section
1139A(b)(2)(E) requires that the
improved core measure sets include (but
not necessarily be limited to) the
following topics and types of healthcare
quality measures:
‘‘(A) The duration of children’s health
insurance coverage over a 12-month time
period.
‘‘(B) The availability and effectiveness of a
full range of—
‘‘(i) preventive services, treatments, and
services for acute conditions, including
services to promote healthy birth, prevent
and treat premature birth, and detect the
presence or risk of physical or mental
conditions that could adversely affect growth
and development; and
‘‘(ii) treatments to correct or ameliorate the
effects of physical and mental conditions,
including chronic conditions, in infants,
PO 00000
Frm 00020
Fmt 4703
Sfmt 4703
young children, school-age children, and
adolescents.
‘‘(C) The availability of care in a range of
ambulatory and inpatient health care settings
in which such care is furnished.
‘‘(D) The types of measures that, taken
together, can be used to estimate the overall
national quality of health care for children,
including children with special needs, and to
perform comparative analyses of pediatric
health care quality and racial, ethnic, and
socioeconomic disparities in child health and
health care for children.
CHIPRA Section 1139A(b)(2)) requires
that the measures developed under the
pediatric quality measures program
shall, at a minimum, be:
‘‘(A) evidence-based and, where
appropriate, risk adjusted;
‘‘(B) designed to identify and eliminate
racial and ethnic disparities in child health
and the provision of health care;
‘‘(C) designed to ensure that the data
required for such measures is collected and
reported in a standard format that permits
comparison of quality and data at a State,
plan, and provider level;
‘‘(D) periodically updated; and
‘‘(E) responsive to the child health needs,
services, and domains of health care quality
described in clauses (i), (ii), and (iii) of
subsection (a)(6)(A).
Definition of healthcare quality
measure. For purposes of this notice, a
healthcare quality measure is defined as
a mechanism that enables a user to
quantify the quality of a selected aspect
of care by comparing it to a criterion
(adapted from https://
www.qualitymeasures.AHRQ.gov/
resources/measure use.aspx).
Definition of healthcare quality. An
Institute of Medicine Committee on a
Future Vision for the National
Healthcare Quality and Disparities
Reports has recently updated the IOM
recommended framework for assessing
and improving quality so that 6
components of quality care are
identified (safety, timeliness,
effectiveness, patient/familycenteredness, access, efficiency), as well
as 2 crosscutting dimensions (equity
and value), three types of care
(preventive care, acute treatment, and
chronic condition management), and
two additional elements (care
coordination, health systems
infrastructure capabilities). (https://
iom.edu/Reports/2010/FutureDirections-for-the-National-HealthcareQuality-and-Disparities-Reports.aspx).
We adopt this framework for purposes
of this public notice.
Prior work to identify priorities for
the POMP. The first phase of CHIPRA
required a process for developing
recommendations for an initial core set
of quality measures for voluntary use by
Medicaid and CHIP programs. As
E:\FR\FM\03DEN1.SGM
03DEN1
mstockstill on DSKH9S0YB1PROD with NOTICES
Federal Register / Vol. 75, No. 232 / Friday, December 3, 2010 / Notices
discussed in the Federal Register Notice
and background paper that
accompanied the public posting of the
initial, recommended core set (https://
www.ahrq.gov/chip/
chipraact.htm#Core), not all CHIPRA
criteria were able to be met for the
initial core set. Public comments on the
initial, recommended core set, and an
expert meeting on measure criteria for
the CHIPRA PQMP (https://
www.AHRQ.gov/chipra/#Expert)
provided additional insights into
potential priorities for the PQMP. The
combination of these efforts and events
led to the identification of the following
potential priorities for measure
enhancement and development of new
measures:
1. Development or enhancement of
methods to:
a. Standardize measures across all
payers, programs, and providers, public
and private, as appropriate, to ensure
that comparisons are valid.
b. Assess disparities in quality by
race, ethnicity, socioeconomic status,
geographic region and residence, and
special health care needs, for example
by developing new measurement
methods or enhancing existing
measurement methods.
c. Adjust for risk by enrollment
duration.
d. Stratify or adjust for risk by depth
and breadth of coverage.
e. Stratify or adjust for risk by medical
conditions, including severity and
acuity.
f. Capitalize on current and coming
investments in health information
technology (e.g., patient and procedure
registries, electronic health records,
health information exchanges,
interoperability), including meaningful
use criteria under the American
Recovery and Reinvestment Act
(ARRA).
g. Increase State programs’ and CMS’s
ability to rely on non-Medicaid and
CHIP data sources through improvement
in public health sector measurement
(e.g., birth certificate data;
immunization surveys).
h. Come to consensus on the meaning
and application of ‘‘evidence-based’’ in
the context of healthcare quality
measurement for children.
i. Incorporate patient and family
perspectives into measurement to
increase understandability.
2. Development or enhancement of
measures in key topic areas:
a. Most integrated healthcare settings.
b. Availability of services.
c. Duration of enrollment as a
standalone measure.
d. Measures of the content (quality) of
care now typically measured as broad
VerDate Mar<15>2010
16:09 Dec 02, 2010
Jkt 223001
utilization categories (e.g., prenatal,
postpartum, newborn care (including
breastfeeding support), well-child and
adolescent well-care visits, screening
services, and follow-up visits for
chronic conditions and related
medications).
e. Specific care settings and
conditions:
i. Perinatal care (e.g., family planning
clinics, obstetric and gynecological care,
birth centers).
ii. Quality of mental/behavioral health
and substance abuse services, including
prevention and treatment services,
across all settings.
iii. Quality of care in settings beyond
traditional medical care settings (e.g.,
for screening, diagnostic services and
therapies).
iv. Inpatient settings (including
specialty inpatient settings).
v. Specialty care for child conditions
and diseases.
vi. Care transitions for patients
transitioning within and across health
care settings.
vii. Additional measures related to
family experiences of care (e.g., child or
adolescent self-reports; perinatal
experiences of care; inpatient
experiences)
viii. Health outcome measures (e.g.,
measures of patient and population
health or other outcomes of
healthcare).2
ix. Structural measures (e.g., measures
of system design features that are
causally linked to improved healthcare
processes and outcomes).
Those submitting comments are
encouraged to include a summary of
evidence for the readiness of a topic for
quality measurement and the
importance of a topic or method.
Additional background information may
be attached. Commenters may wish to
address these issues using the following
questions. Commenters may also wish
to include in their comments a summary
score based on a scale of 1–5, where 1
is a high score, 3 is a medium score, and
5 is a low score.
Validity/Underlying Scientific
Soundness: To what extent is there a
demonstrated causal relationship
between the element of quality to be
measured (as a structure, process, or
health outcome of healthcare delivery)
and another element of the healthcare
delivery system (e.g., structure and
process; process and outcome).
Commenters may wish to use as a guide
to assessing underlying scientific
soundness the method and criteria used
by the AHRQ National Advisory
Council Subcommittee on Children’s
Healthcare Quality Measures for
Medicaid and CHIP, where appropriate
PO 00000
Frm 00021
Fmt 4703
Sfmt 4703
75471
https://www.AHRQ.gov/chipra/
corebackground/
corebacktab.htm#note5).
Importance: Importance has several
dimensions:
• To what extent is the topic
important to children’s health
outcomes, family functioning, or
societal functioning, including but not
necessarily limited to high monetary
costs of poor quality healthcare to
children, families, or Society?
• To what extent is the topic
important to reducing disparities in the
quality of care for particular racial and
ethnic groups of children,
socioeconomic groups, geographically
underserved groups, and children with
special healthcare needs?
• To what extent is the topic
important as a sentinel measure that
could have spillover effects to the rest
of the children’s healthcare delivery
system?
• To what extent is the proposed
methodology important for addressing
current shortcoming of healthcare
quality measurement?
We strongly encourage comments to
be as succinct as possible (250 words or
less per topic, with additional
supporting data allowed).
3. Collection of Information
Requirements
This voluntary request does not
impose information collection and
recordkeeping requirements.
Consequently, it need not be reviewed
by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. 35).
4. Regulatory Impact Analysis
As this notice does not meet the
significance criteria of Executive Order
12866, it was not reviewed by the Office
of Management and Budget.
Dated: November 24, 2010.
Carolyn M. Clancy,
AHRQ Director.
[FR Doc. 2010–30262 Filed 12–2–10; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Patient Safety Organizations:
Voluntary Delisting
Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice of Delisting.
AGENCY:
E:\FR\FM\03DEN1.SGM
03DEN1
]]>Agencies
[Federal Register Volume 75, Number 232 (Friday, December 3, 2010)]
[Notices]
[Pages 75469-75471]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-30262]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Priority Setting for the Children's Health Insurance Program
Reauthorization Act (CHIPRA) Pediatric Quality Measures Program
AGENCY: Agency for Healthcare Research and Quality, HHS.
ACTION: Request for public comments.
-----------------------------------------------------------------------
SUMMARY: Section 401(a) of the Children's Health Insurance Program
Reauthorization Act of 2009 (Pub. L. 111-3) amended title Xl of the
Social Security Act by inserting after section 1139 the new section
1139A, ``Child Health Quality Measures.'': Subsection 1139A(b),
``Advancing and Improving Pediatric Quality Measures,'' directs the
Secretary to establish a pediatric quality measures program to: improve
and strengthen the initial core child health care quality measures
established by the Secretary under section 1139A(a); expand on existing
pediatric quality measures used by public and private health care
purchasers and advance the development of new quality measures; and
increase the portfolio of evidence-based, consensus pediatric quality
measures available to public and private purchasers of children's
healthcare services, providers, and consumers. Section 1139A(b)(3)
requires the Secretary to consult with a broad range of stakeholders to
set these priorities. To meet the requirement for extensive stakeholder
consultation, we are seeking general public comment on these draft
priorities, and asking the public to identify additional priorities as
needed.
DATES: Comments on this notice must be received by January 14, 2010.
The
[[Page 75470]]
public comment period will close on January 14, 2010 at 5 p.m. EST. Any
comments received after the close of the comment period will not be
considered.
ADDRESSES: You may submit comments by any of the following methods:
1. Electronic Mail_CHIPRAqualitymeasures@AHRQ.hhs.gov.
2. Mail--Agency for Healthcare Research and Quality, Attention:
Office of Extramural Research, Education, and Priority Populations-
Public Comment, CHIPRA PQMP Priorities, 540 Gaither Rd., Rockville, MD
20850.
Comments cannot be sent by facsimile transmission, because of staff
and resource limitations. Please note that all submissions may be
posted without change to https://www.AHRQ.gov/chipra, including any
personal information provided.
FOR FURTHER INFORMATION CONTACT:
Denise Dougherty, PhD, Senior Advisor, Child Health and Quality
Improvement, Office of Extramural Research, Education, and Priority
Populations, Agency for Healthcare Research and Quality, 540 Gaither
Rd., Rockville, MD. 301-427-1868. Denise.dougherty@ahrq.hhs.gov.
For information regarding this Notice, please contact:
CHIPRAqualitymeasures@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION: On February 4, 2009, the Congress enacted
the Children's Health Insurance Program Reauthorization Act (CHIPRA) of
2009 (Pub. L. 111-3)., Section 401(a) of the legislation amended title
XI of the Social Security Act (the Act) to establish section 1139A (42
U.S.C. 1320b-9a). Subsection 1139A(b)(E) requires the Secretary to
consult with a wide spectrum of national stakeholders to identify gaps
in existing pediatric quality measures and establish priorities for
development and advancement of such measures. The Secretary delegated
CHIPRA implementation to the Centers for Medicare & Medicaid Services
(CMS). A ``Memorandum of Understanding ``was entered into with the
Agency for Healthcare Research and Quality (AHRQ), by which AHRQ would
conduct several activities in Title IV. These included the
identification of an initial, recommended core set of children's
healthcare quality measures for voluntary use by Medicaid and CHIP
programs and establishment of the Pediatric Quality Measures Program
(PQMP), both in collaboration with CMS.
Pediatric Quality Measures Program (PQMP). The PQMP was required to
be established by January 1, 2011, and authorized to award grants and
contracts. The PQMP will consist of 7-9 cooperative agreement awards to
successful applicants to HS11-001 (https://grants.nih.gov/grants/guide/rfa-files/RFA-HS-11-001.html), and a contract award to a CHIPRA
Coordinating and Technical Assistance Center (https://www.ahrg.gov/chipra/#CTAC), both supervised by AHRQ and CMS. As required by CHIPRA,
successful applicants will work on priorities for measurement methods
and topics set by HHS and informed by the input of multiple
stakeholders.
Multi-stakeholder consultation. Section 1139A(b)(3) requires a
consultation process for establishing priorities for the pediatric
quality measures program that requires consultation with multiple
stakeholders, as follows:
`` * * * the Secretary shall consult with:
``(A) States;
(B) pediatricians, children's hospitals, and other primary and
specialized pediatric health care professionals (including members
of the allied health professions) who specialize in the care and
treatment of children, particularly children with special physical,
mental and developmental health care needs;
(C) dental professionals, including pediatric dental
professionals;
(D) health care providers that furnish primary health care to
children and families who live in urban and rural medically
underserved communities or who are members of distinct population
sub-groups at heightened risk for poor health outcomes;
(E) national organizations representing children, including
children with disabilities and children with chronic conditions;
(F) national organizations representing consumers and purchasers
of children's health care;
(G) national organizations and individuals with expertise in
pediatric health quality measurement; and
(H) voluntary consensus standards setting organizations and
other organizations involved in the advancement of evidence-based
measures of health care.''
Measure topics: Section 1139A(b)(2)(E) requires that the improved
core measure sets include (but not necessarily be limited to) the
following topics and types of healthcare quality measures:
``(A) The duration of children's health insurance coverage over
a 12-month time period.
``(B) The availability and effectiveness of a full range of--
``(i) preventive services, treatments, and services for acute
conditions, including services to promote healthy birth, prevent and
treat premature birth, and detect the presence or risk of physical
or mental conditions that could adversely affect growth and
development; and
``(ii) treatments to correct or ameliorate the effects of
physical and mental conditions, including chronic conditions, in
infants, young children, school-age children, and adolescents.
``(C) The availability of care in a range of ambulatory and
inpatient health care settings in which such care is furnished.
``(D) The types of measures that, taken together, can be used to
estimate the overall national quality of health care for children,
including children with special needs, and to perform comparative
analyses of pediatric health care quality and racial, ethnic, and
socioeconomic disparities in child health and health care for
children.
CHIPRA Section 1139A(b)(2)) requires that the measures developed
under the pediatric quality measures program shall, at a minimum, be:
``(A) evidence-based and, where appropriate, risk adjusted;
``(B) designed to identify and eliminate racial and ethnic
disparities in child health and the provision of health care;
``(C) designed to ensure that the data required for such
measures is collected and reported in a standard format that permits
comparison of quality and data at a State, plan, and provider level;
``(D) periodically updated; and
``(E) responsive to the child health needs, services, and
domains of health care quality described in clauses (i), (ii), and
(iii) of subsection (a)(6)(A).
Definition of healthcare quality measure. For purposes of this
notice, a healthcare quality measure is defined as a mechanism that
enables a user to quantify the quality of a selected aspect of care by
comparing it to a criterion (adapted from https://www.qualitymeasures.AHRQ.gov/resources/measure use.aspx).
Definition of healthcare quality. An Institute of Medicine
Committee on a Future Vision for the National Healthcare Quality and
Disparities Reports has recently updated the IOM recommended framework
for assessing and improving quality so that 6 components of quality
care are identified (safety, timeliness, effectiveness, patient/family-
centeredness, access, efficiency), as well as 2 crosscutting dimensions
(equity and value), three types of care (preventive care, acute
treatment, and chronic condition management), and two additional
elements (care coordination, health systems infrastructure
capabilities). (https://iom.edu/Reports/2010/Future-Directions-for-the-National-Healthcare-Quality-and-Disparities-Reports.aspx). We adopt
this framework for purposes of this public notice.
Prior work to identify priorities for the POMP. The first phase of
CHIPRA required a process for developing recommendations for an initial
core set of quality measures for voluntary use by Medicaid and CHIP
programs. As
[[Page 75471]]
discussed in the Federal Register Notice and background paper that
accompanied the public posting of the initial, recommended core set
(https://www.ahrq.gov/chip/chipraact.htm#Core), not all CHIPRA criteria
were able to be met for the initial core set. Public comments on the
initial, recommended core set, and an expert meeting on measure
criteria for the CHIPRA PQMP (https://www.AHRQ.gov/chipra/#Expert)
provided additional insights into potential priorities for the PQMP.
The combination of these efforts and events led to the identification
of the following potential priorities for measure enhancement and
development of new measures:
1. Development or enhancement of methods to:
a. Standardize measures across all payers, programs, and providers,
public and private, as appropriate, to ensure that comparisons are
valid.
b. Assess disparities in quality by race, ethnicity, socioeconomic
status, geographic region and residence, and special health care needs,
for example by developing new measurement methods or enhancing existing
measurement methods.
c. Adjust for risk by enrollment duration.
d. Stratify or adjust for risk by depth and breadth of coverage.
e. Stratify or adjust for risk by medical conditions, including
severity and acuity.
f. Capitalize on current and coming investments in health
information technology (e.g., patient and procedure registries,
electronic health records, health information exchanges,
interoperability), including meaningful use criteria under the American
Recovery and Reinvestment Act (ARRA).
g. Increase State programs' and CMS's ability to rely on non-
Medicaid and CHIP data sources through improvement in public health
sector measurement (e.g., birth certificate data; immunization
surveys).
h. Come to consensus on the meaning and application of ``evidence-
based'' in the context of healthcare quality measurement for children.
i. Incorporate patient and family perspectives into measurement to
increase understandability.
2. Development or enhancement of measures in key topic areas:
a. Most integrated healthcare settings.
b. Availability of services.
c. Duration of enrollment as a standalone measure.
d. Measures of the content (quality) of care now typically measured
as broad utilization categories (e.g., prenatal, postpartum, newborn
care (including breastfeeding support), well-child and adolescent well-
care visits, screening services, and follow-up visits for chronic
conditions and related medications).
e. Specific care settings and conditions:
i. Perinatal care (e.g., family planning clinics, obstetric and
gynecological care, birth centers).
ii. Quality of mental/behavioral health and substance abuse
services, including prevention and treatment services, across all
settings.
iii. Quality of care in settings beyond traditional medical care
settings (e.g., for screening, diagnostic services and therapies).
iv. Inpatient settings (including specialty inpatient settings).
v. Specialty care for child conditions and diseases.
vi. Care transitions for patients transitioning within and across
health care settings.
vii. Additional measures related to family experiences of care
(e.g., child or adolescent self-reports; perinatal experiences of care;
inpatient experiences)
viii. Health outcome measures (e.g., measures of patient and
population health or other outcomes of healthcare).\2\
ix. Structural measures (e.g., measures of system design features
that are causally linked to improved healthcare processes and
outcomes).
Those submitting comments are encouraged to include a summary of
evidence for the readiness of a topic for quality measurement and the
importance of a topic or method. Additional background information may
be attached. Commenters may wish to address these issues using the
following questions. Commenters may also wish to include in their
comments a summary score based on a scale of 1-5, where 1 is a high
score, 3 is a medium score, and 5 is a low score.
Validity/Underlying Scientific Soundness: To what extent is there a
demonstrated causal relationship between the element of quality to be
measured (as a structure, process, or health outcome of healthcare
delivery) and another element of the healthcare delivery system (e.g.,
structure and process; process and outcome). Commenters may wish to use
as a guide to assessing underlying scientific soundness the method and
criteria used by the AHRQ National Advisory Council Subcommittee on
Children's Healthcare Quality Measures for Medicaid and CHIP, where
appropriate https://www.AHRQ.gov/chipra/corebackground/corebacktab.htm#note5).
Importance: Importance has several dimensions:
To what extent is the topic important to children's health
outcomes, family functioning, or societal functioning, including but
not necessarily limited to high monetary costs of poor quality
healthcare to children, families, or Society?
To what extent is the topic important to reducing
disparities in the quality of care for particular racial and ethnic
groups of children, socioeconomic groups, geographically underserved
groups, and children with special healthcare needs?
To what extent is the topic important as a sentinel
measure that could have spillover effects to the rest of the children's
healthcare delivery system?
To what extent is the proposed methodology important for
addressing current shortcoming of healthcare quality measurement?
We strongly encourage comments to be as succinct as possible (250
words or less per topic, with additional supporting data allowed).
3. Collection of Information Requirements
This voluntary request does not impose information collection and
recordkeeping requirements. Consequently, it need not be reviewed by
the Office of Management and Budget under the authority of the
Paperwork Reduction Act of 1995 (44 U.S.C. 35).
4. Regulatory Impact Analysis
As this notice does not meet the significance criteria of Executive
Order 12866, it was not reviewed by the Office of Management and
Budget.
Dated: November 24, 2010.
Carolyn M. Clancy,
AHRQ Director.
[FR Doc. 2010-30262 Filed 12-2-10; 8:45 am]
BILLING CODE 4160-90-M
